Status:
RECRUITING
Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
ST Elevation Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to investigate and evaluate clinical performance and quality measures for adults with acute ST-elevation myocardial infarction (STEMI) in China. Further more, the investigates like to ...
Detailed Description
Cardiovascular disease (CVD) is a major concern in public health globally, as well as in China, and remarkable variations of resources available and health system performance have been noted. Acute my...
Eligibility Criteria
Inclusion
- Patients with STEMI who arrive at the hospital within 48 hours from the symptoms onset.
Exclusion
- None
Key Trial Info
Start Date :
July 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2035
Estimated Enrollment :
200000 Patients enrolled
Trial Details
Trial ID
NCT04088682
Start Date
July 15 2018
End Date
December 31 2035
Last Update
October 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hongjian Wang
Beijing, Beijing Municipality, China, 100037